Strain sc|0034135


StrainInfo: SI-ID 389404 T

Taxon
Bacteroides fragilisT
Sample
Appendix abscess (GB)
Cultures (21)
LMG 10263 = ATCC 25285 = CCUG 4856 = DSM 2151 = LMG 11261 = NCDO 2217 = NCTC 9343 = CCM 4712 = CCUG 38583 = JCM 11019 = CIP 77.16 = KCTC 2609 = KCTC 5013 = KCTC 3688 = BCRC 10620 = CCRC 10620 = ACM 1145 = ACM 4768 = ACM 5196 = CNCTC 5632 = VTT E-022248
Other Designations (13)
CCTM 2665 = VPI 2553 = Sonnenwirth EN-2 = FIRDI 620 = CN 6300 = CNCTC An 13/83 = CCTM La 2665 = LMG 10263T QC 1/00 = LMG10263T QC 7/05 = Moore, VPI 2553 = LMG 10263T QC 11/99 = Onslow = EN-2
Sequences (60)
Associated Publications (129)
  • DOI: 10.1128/AEM.72.2.1006-1012.2006
    Van der Meulen R, Makras L, Verbrugghe K, Adriany T, De Vuyst L (2006). In vitro kinetic analysis of oligofructose consumption by Bacteroides and Bifidobacterium spp. indicates different degradation mechanisms.
  • DOI: 10.1159/000239551
    Takahata M, Nishino T (1997). Antibacterial activities of tosufloxacin against anaerobic bacteria and the electron micrograph of its bactericidal effects.
  • DOI: 10.1007/s00248-007-9358-3
    Pumbwe L, Skilbeck CA, Wexler HM (2008). Presence of quorum-sensing systems associated with multidrug resistance and biofilm formation in Bacteroides fragilis.
  • DOI: 10.1016/0005-2744(76)90068-1
    Stellwag EJ, Hylemon PB (1976). Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis.
  • DOI: 10.1093/infdis/139.5.534
    Woo DD, Holt SC, Leadbetter ER (1979). Ultrastructure of Bacteroides species: Bacteroides asaccharolyticus, Bacteroides fragilis, Bacteroides melaninogenicus subspecies melaninogenicus, and B. melaninogenicus subspecies intermedius.
  • DOI: 10.1128/jcm.8.5.553-557.1978
    Wilkins TD, Wagner DL, Veltri BJ Jr, Gregory EM (1978). Factors affecting production of catalase by Bacteroides.
  • DOI: 10.1128/jcm.30.4.806-812.1992
    Smith CJ, Callihan DR (1992). Analysis of rRNA restriction fragment length polymorphisms from Bacteroides spp. and Bacteroides fragilis isolates associated with diarrhea in humans and animals.
  • DOI: 10.1128/jcm.28.3.405-408.1990
    Dinsmoor MJ, Ebersole JE, Gibbs RS (1990). Protein banding patterns of the outer membrane-enriched fraction of Bacteroides bivius.
  • DOI: 10.1128/AAC.33.2.242
    Muto Y, Bandoh K, Watanabe K, Katoh N, Ueno K (1989). Macrolide accumulation by Bacteroides fragilis ATCC 25285.
  • DOI: 10.1128/jcm.26.4.776-777.1988
    Barry AL, Jones RN (1988). Evaluation of in vitro methods for testing ceftriaxone against anaerobic bacteria, including quality control guidelines.
  • DOI: 10.1128/AAC.32.12.1825
    Flaherty JF, Rodondi LC, Guglielmo BJ, Fleishaker JC, Townsend RJ, Gambertoglio JG (1988). Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens.
  • DOI: 10.1093/jac/21.4.425
    King A, Phillips I (1988). European collaborative study of reproducibility of quantitative sensitivity testing of anaerobes.
  • DOI: 10.1016/0732-8893(87)90154-4
    Jones RN, Barry AL, Fuchs PC, Allen SD (1987). Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure.
  • DOI: 10.1128/aem.43.2.325-330.1982
    Roberton AM, Stanley RA (1982). In vitro utilization of mucin by Bacteroides fragilis.
  • Wannemuehler MJ, Michalek SM, Jirillo E, Williamson SI, Hirasawa M, McGhee JR (1984). LPS regulation of the immune response: Bacteroides endotoxin induces mitogenic, polyclonal, and antibody responses in classical LPS responsive but not C3H/HeJ mice.
  • Williamson SI, Wannemuehler MJ, Jirillo E, Pritchard DG, Michalek SM, McGhee JR (1984). LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS.
  • DOI: 10.1128/jb.145.1.466-471.1981
    Chen M, Wolin MJ (1981). Influence of heme and vitamin B12 on growth and fermentations of Bacteroides species.
  • DOI: 10.1128/AAC.37.11.2454
    Zabinski RA, Vance-Bryan K, Krinke AJ, Walker KJ, Moody JA, Rotschafer JC (1993). Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.
  • DOI: 10.1086/516200
    Claros MC, Hunt Gerardo S, Citron DM, Goldstein EJ, Schonian G, Rodloff AC (1997). Use of polymerase chain reaction fingerprinting to compare clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron from Germany and the United States.
  • DOI: 10.1093/jac/41.3.387
    Ednie LM, Jacobs MR, Appelbaum PC (1998). Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2.
  • Avelar KE, Moraes SR, Pinto LJ, Silva e Souza W das G, Domingues RM, Ferreira MC (1998). Influence of stress conditions on Bacteroides fragilis survival and protein profiles.
  • DOI: 10.1111/j.1574-6968.1998.tb13911.x
    Odou MF, Singer E, Romond MB, Dubreuil L (1998). Isolation and characterization of a porin-like protein of 45 kilodaltons from Bacteroides fragilis.
  • DOI: 10.1128/JB.181.1.246-255.1999
    Barkocy-Gallagher GA, Foley JW, Lantz MS (1999). Activities of the Porphyromonas gingivalis PrtP proteinase determined by construction of prtP-deficient mutants and expression of the gene in Bacteroides species.
  • DOI: 10.1016/s0923-2508(99)80050-3
    Moraes SR, Goncalves RB, Mouton C, Seldin L, Ferreira MC, Domingues RM (1999). Bacteroides fragilis isolates compared by AP-PCR.
  • DOI: 10.1128/AAC.44.7.1842-1845.2000
    Bachoual R, Dubreuil L, Soussy CJ, Tankovic J (2000). Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacin.
  • DOI: 10.1016/s0732-8893(00)00219-4
    White RL, Friedrich LV, Manduru M, Mihm LB, Bosso JA (2001). Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilis.
  • DOI: 10.1128/AAC.46.1.203-210.2002
    Peterson ML, Hovde LB, Wright DH, Brown GH, Hoang AD, Rotschafer JC (2002). Pharmacodynamics of trovafloxacin and levofloxacin against Bacteroides fragilis in an in vitro pharmacodynamic model.
  • DOI: 10.1016/s0378-1119(01)00835-6
    Wexler HM, Read EK, Tomzynski TJ (2002). Characterization of omp200, a porin gene complex from Bacteroides fragilis: omp121 and omp71, gene sequence, deduced amino acid sequences and predictions of porin structure.
  • DOI: 10.1089/109264203766207690
    Sare M, Demirkiran AE, Tastekin N, Durmaz B (2003). Effects of laparoscopic models on anaerobic bacterial growth with bacteroides fragilis in experimentally induced peritonitis.
  • DOI: 10.1093/jac/dkg418
    Ricci V, Piddock L (2003). Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones.
  • DOI: 10.1007/s00284-003-4079-4
    Bennett MJ, McKnight SL, Coleman JP (2003). Cloning and characterization of the NAD-dependent 7alpha-Hydroxysteroid dehydrogenase from Bacteroides fragilis.
  • DOI: 10.1093/jac/dkh256
    Diniz CG, Farias LM, Carvalho MA, Rocha ER, Smith CJ (2004). Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant.
  • DOI: 10.1007/s15010-005-5061-9
    Schaumann R, Petzold S, Fille M, Rodloff AC (2005). Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
  • DOI: 10.1006/anae.1999.0183
    Fang H, Hedberg M, Edlund C, Jarstrand C, Fodor E, Nord CE (1999). Characterization of beta-lactam-resistant Bacteroides fragilis isolates by use of PCR fingerprinting.
  • DOI: 10.1093/jac/dkm363
    Pumbwe L, Skilbeck CA, Wexler HM (2007). Induction of multiple antibiotic resistance in Bacteroides fragilis by benzene and benzene-derived active compounds of commonly used analgesics, antiseptics and cleaning agents.
  • DOI: 10.1179/joc.2010.22.4.259
    Valeria Dos Santos K, Roque DE Carvalho MA, Amancio Martins W, Coutinho SC, Bahia JL, Lopes DE Andrade JP, Morais Apolonio AC, Cara DC, Galuppo Diniz C, Nicoli JR, DE Macedo Farias L (2010). In vitro selection of ertapenem and piperacillin/tazobactam-resistant strains of Bacteroides fragilis and analysis of their virulence in gnotobiotic mice.
  • DOI: 10.1016/j.steroids.2011.05.001
    Liu Y, Lv T, Ren J, Wang M, Wu Q, Zhu D (2011). The catalytic promiscuity of a microbial 7alpha-hydroxysteroid dehydrogenase. Reduction of non-steroidal carbonyl compounds.
  • DOI: 10.1007/s00262-012-1205-9
    De Silva RA, Appulage DK, Pietraszkiewicz H, Bobbitt KR, Media J, Shaw J, Valeriote FA, Andreana PR (2012). The entirely carbohydrate immunogen Tn-PS A1 induces a cancer cell selective immune response and cytokine IL-17.
  • DOI: 10.1016/j.ijantimicag.2012.09.013
    Mathur T, Kalia V, Barman TK, Singhal S, Khan S, Upadhyay DJ, Rattan A, Raj VS (2012). Anti-anaerobic potential of ranbezolid: insight into its mechanism of action against Bacteroides fragilis.
  • DOI: 10.1039/C4MD00038B
    Trabbic KR, De Silva RA, Andreana PR (2014). Elucidating Structural Features of an Entirely Carbohydrate Cancer Vaccine Construct Employing Circular Dichroism and Fluorescent Labeling.
  • DOI: 10.1039/c6ob00176a
    Trabbic KR, Bourgault JP, Shi M, Clark M, Andreana PR (2016). Immunological evaluation of the entirely carbohydrate-based Thomsen-Friedenreich - PS B conjugate.
  • DOI: 10.1021/acs.joc.6b00195
    Ghosh S, Nishat S, Andreana PR (2016). Synthesis of an Aminooxy Derivative of the Tetrasaccharide Repeating Unit of Streptococcus dysgalactiae 2023 Polysaccharide for a PS A1 Conjugate Vaccine.
  • Justesen US (2016). [Design of artificial foetor flatus based on bacterial volatile compounds].
  • DOI: 10.3389/fmicb.2017.00435
    Wang Y, Deng H, Li Z, Tan Y, Han Y, Wang X, Du Z, Liu Y, Yang R, Bai Y, Bi Y, Zhi F (2017). Safety Evaluation of a Novel Strain of Bacteroides fragilis.
  • DOI: 10.1007/s00430-017-0513-2
    Kierzkowska M, Pedzisz P, Babiak I, Janowicz J, Kulig M, Majewska A, Sawicka-Grzelak A, Mlynarczyk G (2017). Orthopedic infections caused by obligatory anaerobic Gram-negative rods: report of two cases.
  • DOI: 10.1016/j.anaerobe.2018.02.007
    Justesen US, Acar Z, Sydenham TV, Johansson A (2018). Antimicrobial susceptibility testing of Bacteroides fragilis using the MALDI Biotyper antibiotic susceptibility test rapid assay (MBT-ASTRA).
  • DOI: 10.1021/acs.orglett.8b01829
    Eradi P, Ghosh S, Andreana PR (2018). Total Synthesis of Zwitterionic Tetrasaccharide Repeating Unit from Bacteroides fragilis ATCC 25285/NCTC 9343 Capsular Polysaccharide PS A1 with Alternating Charges on Adjacent Monosaccharides.
  • DOI: 10.1099/mgen.0.000312
    Sydenham TV, Overballe-Petersen S, Hasman H, Wexler H, Kemp M, Justesen US (2019). Complete hybrid genome assembly of clinical multidrug-resistant Bacteroides fragilis isolates enables comprehensive identification of antimicrobial-resistance genes and plasmids.
  • DOI: 10.1016/j.ejphar.2020.173421
    Li D, Pan Y, Xia X, Liang J, Liu F, Dou H, Hou Y (2020). Bacteroides fragilis alleviates the symptoms of lupus nephritis via regulating CD1d and CD86 expressions in B cells.
  • DOI: 10.1007/s00253-022-11946-7
    Wang Q, Li Y, Lv L, Jiang H, Yan R, Wang S, Lu Y, Wu Z, Shen J, Jiang S, Lv J, Li S, Zhuge A, Li L (2022). Identification of a protective Bacteroides strain of alcoholic liver disease and its synergistic effect with pectin.
  • DOI: 10.1038/s41598-023-42481-8
    He Q, Niu M, Bi J, Du N, Liu S, Yang K, Li H, Yao J, Du Y, Duan Y (2023). Protective effects of a new generation of probiotic Bacteroides fragilis against colitis in vivo and in vitro.
  • DOI: 10.5578/mb.20249906
    Altan G, Budak F (2024). [Investigation of the Antibacterial Effect of Taraxacum officinale Extracts Extracted in Different Solvents on Bacteroides fragilis ATCC 25285 Standard Strain by Broth Microdilution Method].
  • DOI: 10.1099/00221287-134-10-2815
    Amann R, Ludwig W, Schleifer KH (1988). Beta-subunit of ATP-synthase: a useful marker for studying the phylogenetic relationship of eubacteria.
  • DOI: 10.1128/aem.55.11.2894-2898.1989
    Allison C, Macfarlane GT (1989). Influence of pH, nutrient availability, and growth rate on amine production by Bacteroides fragilis and Clostridium perfringens.
  • DOI: 10.1016/0378-1097(91)90567-t
    Macfarlane GT, Gibson GR (1991). Formation of glycoprotein degrading enzymes by Bacteroides fragilis.
  • DOI: 10.1099/00221287-134-1-19
    Gibson SA, Macfarlane GT (1988). Studies on the proteolytic activity of Bacteroides fragilis.
  • DOI: 10.1099/00221287-134-8-2231
    Gibson SA, Macfarlane GT (1988). Characterization of proteases formed by Bacteroides fragilis.
  • DOI: 10.3109/00016358909007712
    Schenck K, Porter SR, Tollefsen T, Johansen JR, Scully C (1989). Serum levels of antibodies against Actinobacillus actinomycetemcomitans in various forms of human periodontitis.
  • DOI: 10.1177/019459989310900322
    Norlander T, Fukami M, Westrin KM, Stierna P, Carlsoo B (1993). Formation of mucosal polyps in the nasal and maxillary sinus cavities by infection.
  • DOI: 10.1016/j.bbapap.2013.12.008
    Chen K, Reuter M, Sanghvi B, Roberts GA, Cooper LP, Tilling M, Blakely GW, Dryden DT (2013). ArdA proteins from different mobile genetic elements can bind to the EcoKI Type I DNA methyltransferase of E. coli K12.
  • DOI: 10.1016/j.micpath.2019.103619
    Valentine M, Benade E, Mouton M, Khan W, Botha A (2019). Binary interactions between the yeast Candida albicans and two gut-associated Bacteroides species.
  • DOI: 10.1111/j.1699-0463.1977.tb01668.x
    Hofstad T (1977). Cross-reactivity of Bacteroides fragilis O antigens.
  • DOI: 10.1007/BF02120807
    Weintraub A, Lindberg AA, Nord CE (1979). Identification of Bacteroides fragilis by indirect immunofluorescence.
  • DOI: 10.1111/j.1699-0463.1975.tb00068.x
    Dalland E, Hofstad T (1975). Production of cell-bound antigens by Bacteroides fragilis nctc 9343 in continuous culture.
  • DOI: 10.1093/oxfordjournals.jbchem.a132528
    Miyagawa E, Azuma R, Suto T, Yano I (1979). Occurrence of free ceramides in Bacteroides fragilis NCTC 9343.
  • DOI: 10.1111/j.1699-0463.1976.tb01930.x
    Hofstad T (1976). Purification of the O antigen of Bacteroides fragilis ss. fragilis NCTC 9343 from phenol-water extracts by gel filtration and chromatography on deae-cellulose and hydroxylapatite.
  • DOI: 10.3109/00016489209100791
    Westrin KM, Norlander T, Stierna P, Carlsoo B, Nord CE (1992). Experimental maxillary sinusitis induced by Bacteroides fragilis. A bacteriological and histological study in rabbits.
  • Tzianabos AO, Pantosti A, Baumann H, Brisson JR, Jennings HJ, Kasper DL (1992). The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides.
  • DOI: 10.1016/0378-1097(92)90418-n
    Azeddoug H, Reysset G, Sebald M (1992). Characterization of restriction endonuclease BfrBI from Bacteroides fragilis strains BE3 and AIP 10006.
  • Ayyagari A, Khanna T, Devi S (1992). Enzyme linked immunosorbent assay & indirect fluorescence assay for rapid diagnosis of Bacteroides fragilis infections.
  • DOI: 10.1099/00222615-35-4-229
    Lutton DA, Patrick S, Crockard AD, Stewart LD, Larkin MJ, Dermott E, McNeill TA (1991). Flow cytometric analysis of within-strain variation in polysaccharide expression by Bacteroides fragilis by use of murine monoclonal antibodies.
  • DOI: 10.1007/BF01726458
    Westrin KM, Stierna P, Weintraub A, Palmgren AC, Nord CE (1991). Serum antibody response to Bacteroides fragilis in experimental sinusitis.
  • DOI: 10.1128/iai.59.6.2075-2082.1991
    Pantosti A, Tzianabos AO, Onderdonk AB, Kasper DL (1991). Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis.
  • DOI: 10.1111/j.1432-1033.1989.tb14945.x
    Weintraub A, Zahringer U, Wollenweber HW, Seydel U, Rietschel ET (1989). Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide.
  • DOI: 10.1099/00221287-133-1-171
    Reid JH, Patrick S, Tabaqchali S (1987). Immunochemical characterization of a polysaccharide antigen of Bacteroides fragilis with an IgM monoclonal antibody.
  • DOI: 10.1111/j.1432-1033.1985.tb09154.x
    Weintraub A, Zahringer U, Lindberg AA (1985). Structural studies of the polysaccharide part of the cell wall lipopolysaccharide from Bacteroides fragilis NCTC 9343.
  • DOI: 10.1128/am.28.5.856-860.1974
    Dalland E, Hofstad T (1974). Growth of Bacteroides fragilis in continuous culture and in batch cultures at controlled pH.
  • DOI: 10.1128/jb.153.2.991-997.1983
    Kasper DL, Weintraub A, Lindberg AA, Lonngren J (1983). Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization.
  • DOI: 10.1128/jcm.20.3.519-524.1984
    Linko-Kettunen L, Arstila P, Jalkanen M, Jousimies-Somer H, Lassila O, Lehtonen OP, Weintraub A, Viljanen MK (1984). Monoclonal antibodies to Bacteroides fragilis lipopolysaccharide.
  • DOI: 10.1093/clinids/6.supplement_1.s25
    Kasper DL, Lindberg AA, Weintraub A, Onderdonk AB, Lonngren J (1984). Capsular polysaccharides and lipopolysaccharides from two strains of Bacteroides fragilis.
  • DOI: 10.1099/00222615-17-3-237
    Patrick S, Reid JH, Larkin MJ (1984). The growth and survival of capsulate and non-capsulate Bacteroides fragilis in vivo and in vitro.
  • Sawicka-Grzelak A, Polna I, Meisel-Mikolajczyk F (1980). Cytopathogenic effect caused by Bacteroides fragilis endotoxin.
  • DOI: 10.1111/j.1699-0463.1981.tb00179_89b.x
    Hofstad T (1981). Precipitating carbohydrate antigens of Bacteroides fragilis NCTC 9343.
  • DOI: 10.1128/jb.144.3.898-903.1980
    Wollenweber HW, Rietschel ET, Hofstad T, Weintraub A, Lindberg AA (1980). Nature, type of linkage, quantity, and absolute configuration of (3-hydroxy) fatty acids in lipopolysaccharides from Bacteroides fragilis NCTC 9343 and related strains.
  • DOI: 10.1128/jcm.31.7.1850-1855.1993
    Pantosti A, Tzianabos AO, Reinap BG, Onderdonk AB, Kasper DL (1993). Bacteroides fragilis strains express multiple capsular polysaccharides.
  • DOI: 10.1006/mpat.1996.0018
    Patrick S, McKenna JP, O'Hagan S, Dermott E (1996). A comparison of the haemagglutinating and enzymic activities of Bacteroides fragilis whole cells and outer membrane vesicles.
  • DOI: 10.1006/jsre.1997.5248
    Sato TT, Kovacich JC, Boyle EM Jr, Haddix TL, Weintraub A, Pohlman TH (1998). CD14-dependent activation of human endothelial cells by Bacteroides fragilis outer membrane.
  • DOI: 10.1128/JB.181.19.6192-6196.1999
    Comstock LE, Coyne MJ, Tzianabos AO, Kasper DL (1999). Interstrain variation of the polysaccharide B biosynthesis locus of Bacteroides fragilis: characterization of the region from strain 638R.
  • DOI: 10.4049/jimmunol.164.2.719
    Kalka-Moll WM, Tzianabos AO, Wang Y, Carey VJ, Finberg RW, Onderdonk AB, Kasper DL (2000). Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity.
  • DOI: 10.1128/AAC.44.9.2361-2366.2000
    Ricci V, Piddock LJ (2000). Accumulation of norfloxacin by Bacteroides fragilis.
  • DOI: 10.1128/IAI.68.11.6176-6181.2000
    Coyne MJ, Kalka-Moll W, Tzianabos AO, Kasper DL, Comstock LE (2000). Bacteroides fragilis NCTC9343 produces at least three distinct capsular polysaccharides: cloning, characterization, and reassignment of polysaccharide B and C biosynthesis loci.
  • DOI: 10.1128/IAI.69.4.2339-2344.2001
    Kalka-Moll WM, Wang Y, Comstock LE, Gonzalez SE, Tzianabos AO, Kasper DL (2001). Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain.
  • DOI: 10.1099/mic.0.26166-0
    Patrick S, Parkhill J, McCoy LJ, Lennard N, Larkin MJ, Collins M, Sczaniecka M, Blakely G (2003). Multiple inverted DNA repeats of Bacteroides fragilis that control polysaccharide antigenic variation are similar to the hin region inverted repeats of Salmonella typhimurium.
  • Zhou J, Huang XY, Ren LC, Tang Y (2003). [The influence of the LPS from Bacteroides fragilis on the secretion of IL-2 and IL-4 from the peripheral blood mononuclear cells of normal volunteers].
  • DOI: 10.1128/JB.186.18.6077-6092.2004
    Franco AA (2004). The Bacteroides fragilis pathogenicity island is contained in a putative novel conjugative transposon.
  • DOI: 10.1128/JB.187.8.2858-2869.2005
    Bacic M, Parker AC, Stagg J, Whitley HP, Wells WG, Jacob LA, Smith CJ (2005). Genetic and structural analysis of the Bacteroides conjugative transposon CTn341.
  • DOI: 10.1128/IAI.74.4.2304-2316.2006
    Robertson KP, Smith CJ, Gough AM, Rocha ER (2006). Characterization of Bacteroides fragilis hemolysins and regulation and synergistic interactions of HlyA and HlyB.
  • DOI: 10.1128/AEM.01669-06
    Buckwold SL, Shoemaker NB, Sears CL, Franco AA (2006). Identification and characterization of conjugative transposons CTn86 and CTn9343 in Bacteroides fragilis strains.
  • DOI: 10.1111/j.1469-0691.2006.01620.x
    Pumbwe L, Wareham DW, Aduse-Opoku J, Brazier JS, Wexler HM (2007). Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis.
  • DOI: 10.1016/j.micpath.2007.04.002
    Pumbwe L, Skilbeck CA, Nakano V, Avila-Campos MJ, Piazza RM, Wexler HM (2007). Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis.
  • DOI: 10.1271/bbb.80691
    Senoura T, Taguchi H, Ito S, Hamada S, Matsui H, Fukiya S, Yokota A, Watanabe J, Wasaki J, Ito S (2009). Identification of the cellobiose 2-epimerase gene in the genome of Bacteroides fragilis NCTC 9343.
  • DOI: 10.1099/mic.0.025361-0
    Patrick S, Houston S, Thacker Z, Blakely GW (2009). Mutational analysis of genes implicated in LPS and capsular polysaccharide biosynthesis in the opportunistic pathogen Bacteroides fragilis.
  • DOI: 10.1128/AEM.02420-09
    Ichimura M, Nakayama-Imaohji H, Wakimoto S, Morita H, Hayashi T, Kuwahara T (2010). Efficient electrotransformation of Bacteroides fragilis.
  • DOI: 10.1099/mic.0.038588-0
    Houston S, Blakely GW, McDowell A, Martin L, Patrick S (2010). Binding and degradation of fibrinogen by Bacteroides fragilis and characterization of a 54 kDa fibrinogen-binding protein.
  • DOI: 10.1099/mic.0.042978-0
    Patrick S, Blakely GW, Houston S, Moore J, Abratt VR, Bertalan M, Cerdeno-Tarraga AM, Quail MA, Corton N, Corton C, Bignell A, Barron A, Clark L, Bentley SD, Parkhill J (2010). Twenty-eight divergent polysaccharide loci specifying within- and amongst-strain capsule diversity in three strains of Bacteroides fragilis.
  • DOI: 10.1016/j.bbrc.2011.04.095
    Senoura T, Ito S, Taguchi H, Higa M, Hamada S, Matsui H, Ozawa T, Jin S, Watanabe J, Wasaki J, Ito S (2011). New microbial mannan catabolic pathway that involves a novel mannosylglucose phosphorylase.
  • DOI: 10.1099/jmm.0.031336-0
    Nagy E, Becker S, Soki J, Urban E, Kostrzewa M (2011). Differentiation of division I (cfiA-negative) and division II (cfiA-positive) Bacteroides fragilis strains by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
  • DOI: 10.1128/JB.05337-11
    Coyne MJ, Fletcher CM, Reinap B, Comstock LE (2011). UDP-glucuronic acid decarboxylases of Bacteroides fragilis and their prevalence in bacteria.
  • DOI: 10.1099/mic.0.049940-0
    Patrick S, Jobling KL, O'Connor D, Thacker Z, Dryden DTF, Blakely GW (2011). A unique homologue of the eukaryotic protein-modifier ubiquitin present in the bacterium Bacteroides fragilis, a predominant resident of the human gastrointestinal tract.
  • DOI: 10.1016/j.anaerobe.2012.04.005
    Suzuki N, Fukamachi H, Arimoto T, Yamamoto M, Igarashi T (2012). Contribution of hly homologs to the hemolytic activity of Prevotella intermedia.
  • DOI: 10.1177/1753425912454179
    Hashimoto M, Eguchi H, Tawaratsumida K, Kirikae T, Suda Y (2012). Identification of a TLR2-stimulating lipoprotein in Bacteroides fragilis JCM 11019 (NCTC 9343).
  • DOI: 10.1371/journal.pbio.1001610
    Wieland Brown LC, Penaranda C, Kashyap PC, Williams BB, Clardy J, Kronenberg M, Sonnenburg JL, Comstock LE, Bluestone JA, Fischbach MA (2013). Production of alpha-galactosylceramide by a prominent member of the human gut microbiota.
  • DOI: 10.1007/s00203-013-0938-y
    Kawaguchi K, Senoura T, Ito S, Taira T, Ito H, Wasaki J, Ito S (2013). The mannobiose-forming exo-mannanase involved in a new mannan catabolic pathway in Bacteroides fragilis.
  • DOI: 10.1371/journal.pone.0091141
    Galvao BP, Weber BW, Rafudeen MS, Ferreira EO, Patrick S, Abratt VR (2014). Identification of a collagen type I adhesin of Bacteroides fragilis.
  • Liu Y, Zhang W, Bai Y, Zhi F (2014). [Isolation and identification of a non-enterotoxigenic strain of Bacteroides fragilis from a healthy term infant].
  • DOI: 10.1371/journal.pone.0117732
    Wilson MM, Anderson DE, Bernstein HD (2015). Analysis of the outer membrane proteome and secretome of Bacteroides fragilis reveals a multiplicity of secretion mechanisms.
  • DOI: 10.1107/S1399004715003326
    Ngo A, Fong KT, Cox DL, Chen X, Fisher AJ (2015). Structures of Bacteroides fragilis uridine 5'-diphosphate-N-acetylglucosamine (UDP-GlcNAc) acyltransferase (BfLpxA).
  • DOI: 10.1371/journal.pone.0148887
    Nakayama-Imaohji H, Hirota K, Yamasaki H, Yoneda S, Nariya H, Suzuki M, Secher T, Miyake Y, Oswald E, Hayashi T, Kuwahara T (2016). DNA Inversion Regulates Outer Membrane Vesicle Production in Bacteroides fragilis.
  • DOI: 10.1007/s00253-016-7464-1
    Gong W, Xu L, Gu G, Lu L, Xiao M (2016). Efficient and regioselective synthesis of globotriose by a novel alpha-galactosidase from Bacteroides fragilis.
  • DOI: 10.1038/s41385-018-0085-5
    Chan JL, Wu S, Geis AL, Chan GV, Gomes TAM, Beck SE, Wu X, Fan H, Tam AJ, Chung L, Ding H, Wang H, Pardoll DM, Housseau F, Sears CL (2018). Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A.
  • DOI: 10.1007/s00253-020-10759-w
    Liu P, Zhang H, Wang Y, Chen X, Jin L, Xu L, Xiao M (2020). Screening and characterization of an alpha-L-fucosidase from Bacteroides fragilis NCTC9343 for synthesis of fucosyl-N-acetylglucosamine disaccharides.
  • DOI: 10.3390/antibiotics10030304
    Valdezate S, Cobo F, Monzon S, Medina-Pascual MJ, Zaballos A, Cuesta I, Pino-Rosa S, Villalon P (2021). Genomic Background and Phylogeny of cfiA-Positive Bacteroides fragilis Strains Resistant to Meropenem-EDTA.
  • DOI: 10.1128/spectrum.01954-21
    Kralova S, Davidova-Gerzova L, Valcek A, Bezdicek M, Rychlik I, Rezacova V, Cizek A (2022). Paraphocaeicola brunensis gen. nov., sp. nov., Carrying Two Variants of nimB Resistance Gene from Bacteroides fragilis, and Caecibacteroides pullorum gen. nov., sp. nov., Two Novel Genera Isolated from Chicken Caeca.
  • DOI: 10.3389/fimmu.2022.931871
    Ling N, Zhang X, Forsythe S, Zhang D, Shen Y, Zhang J, Ding Y, Wang J, Wu Q, Ye Y (2022). Bacteroides fragilis ameliorates Cronobacter malonaticus lipopolysaccharide-induced pathological injury through modulation of the intestinal microbiota.
  • DOI: 10.1016/j.celrep.2023.112781
    He W, Wu K, Ouyang Z, Bai Y, Luo W, Wu D, An H, Guo Y, Jiao M, Qin Q, Zhang J, Wu Y, She J, Hwang PM, Zheng F, Zhu L, Wen Y (2023). Structure and assembly of type VI secretion system cargo delivery vehicle.
  • DOI: 10.1016/j.ijbiomac.2024.130955
    Wang N, Zhu Y, Wang L, Huang Z, Li Z, Xu W, Mu W (2024). Highly-efficient in vivo production of lacto-N-fucopentaose V by a regio-specific alpha1,3/4-fucosyltransferase from Bacteroides fragilis NCTC 9343.
  • DOI: 10.1093/jac/dkae166
    Valdezate S, Medina-Pascual MJ, Villalon P, Garrido N, Monzon S, Cuesta I, Cobo F (2024). Co-occurrence of the cephalosporinase cepA and carbapenemase cfiA genes in a Bacteroides fragilis division II strain, an unexpected finding.
  • DOI: 10.1111/j.1574-6968.2009.01531.x
    Fukiya S, Arata M, Kawashima H, Yoshida D, Kaneko M, Minamida K, Watanabe J, Ogura Y, Uchida K, Itoh K, Wada M, Ito S, Yokota A (2009). Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives by Bacteroides intestinalis AM-1 isolated from human feces.
  • DOI: 10.1007/s00253-013-5188-z
    Kobayashi A, Sano D, Taniuchi A, Ishii S, Okabe S (2013). Use of a genetically-engineered Escherichia coli strain as a sample process control for quantification of the host-specific bacterial genetic markers.
Outside links and data sources
Retrieved about 1 month ago via StrainInfo API (CC BY 4.0)

Genomics

Genomes (1)

Metadata

Cannonical URL
https://seqco.de/s:34135
Local history
  • Registered 8 months ago
  • Last modified about 1 month ago
© 2022-2025 The SeqCode Initiative
  All information contributed to the SeqCode Registry is released under the terms of the Creative Commons Attribution (CC BY) 4.0 license